Found: 5
Select item for more details and to access through your institution.
Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231152843
- By:
- Publication type:
- Article
Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
- Published in:
- Molecular & Cellular Biochemistry, 2015, v. 405, n. 1/2, p. 205, doi. 10.1007/s11010-015-2412-4
- By:
- Publication type:
- Article
Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2− Advanced Breast Cancer: Findings From a Multicountry Survey.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 856, doi. 10.1093/oncolo/oyad207
- By:
- Publication type:
- Article
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 375
- By:
- Publication type:
- Article
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161202
- By:
- Publication type:
- Article